#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15458	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2504	760.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1846	1846	T	956	T,C,G	953,1,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15458	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2504	760.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1580	1580	C	986	C,A	985,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15458	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2504	760.6	0	HET	.	.	.	C1269T,G	.	1269	1269	C	1665	1665	C	1025	C,T,G	808,216,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25718	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3964	808.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1882	1882	A	1144	A,C	1143,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25718	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3964	808.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2516	2516	C	912	C,T	910,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25718	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3964	808.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2590	2590	A	797	A,T	796,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25718	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3964	808.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3142	3142	C	935	C,A,G	932,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2422	folP	852	852	99.88	folP.l15.c4.ctg.1	2005	150.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	991	993	AAA	256;252;253	A;A;A,C	256;252;252,1	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2422	folP	852	852	99.88	folP.l15.c4.ctg.1	2005	150.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1222	1224	AGC	232;233;232	A;G;C	232;233;232	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5388	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3846	174.6	0	.	p	.	0	K261del	DEL	781	781	A	1354	1354	A	217	A,C	216,1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5388	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3846	174.6	1	SNP	p	S91F	0	.	.	271	273	TCC	844	846	TCC	210;210;209	T;C;C	210;210;209	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5388	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3846	174.6	1	SNP	p	D95G	0	.	.	283	285	GAC	856	858	GAC	217;218;218	G,T;A,G;C	216,1;217,1;218	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5388	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3846	174.6	1	SNP	p	D95N	0	.	.	283	285	GAC	856	858	GAC	217;218;218	G,T;A,G;C	216,1;217,1;218	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2202	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1748	157.0	1	SNP	p	G45D	0	.	.	133	135	GGC	689	691	GGC	230;231;230	G;G;C	230;231;230	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1140	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1466	97.0	0	.	n	.	0	A197.	DEL	197	197	A	850	850	A	228	A	228	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5130	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3441	185.8	1	SNP	p	D86N	0	.	.	256	258	GAC	833	835	GAC	248;250;250	G;A;C	248;250;250	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5130	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3441	185.8	1	SNP	p	S87W	0	.	.	259	261	AGT	836	838	AGT	252;256;256	A,C,T;G;T	249,2,1;256;256	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5130	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3441	185.8	1	SNP	p	S87I	0	.	.	259	261	AGT	836	838	AGT	252;256;256	A,C,T;G;T	249,2,1;256;256	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5130	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3441	185.8	1	SNP	p	S87R	0	.	.	259	261	AGT	836	838	AGT	252;256;256	A,C,T;G;T	249,2,1;256;256	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5130	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3441	185.8	1	SNP	p	S88P	0	.	.	262	264	TCC	839	841	TCC	256;257;258	T;C,A;C,T	256;256,1;257,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4504	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3109	180.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1820	1822	GGC	283;283;279	G,C;G,T;C,A	282,1;281,2;278,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1556	1558	GCA	260;259;258	G,T;C,T;A	259,1;258,1;258	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1559	1561	ATC	258;255;260	A;T;C	258;255;260	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1571	1573	GTG	253;254;251	G;T;G,T	253;254;250,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1571	1573	GTG	253;254;251	G;T;G,T	253;254;250,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2075	2077	ACC	256;255;256	A;C,G,A;C	256;253,1,1;256	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2129	2131	GCG	231;229;228	G;C;G,T	231;229;227,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2129	2131	GCG	231;229;228	G;C;G,T	231;229;227,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2252	2254	GGC	207;206;206	G;G;C,G	207;206;205,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2261	2263	GGC	210;211;215	G,C;G;C,G	207,3;211;214,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4380	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	184.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2279	2281	CTG	252;253;250	C,G;T;G,A	251,1;253;249,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5834	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3515	207.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1817	1819	CCG	227;226;228	C,G;C,T;G,A	226,1;225,1;227,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2574	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2196	146.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	751	751	C	202	C	202	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	100	95.0	porB1a.l15.c17.ctg.2	182	55.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	70;69;65	A;C;G	70;69;65	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	100	95.0	porB1a.l15.c17.ctg.2	182	55.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	18;15;11	C;A;A	18;15;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	26;27;29	T;T;A	26;27;29	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	62;62;62	C;A;T	62;62;62	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	D274G	NONSYN	820	822	GAT	62	64	GGT	62;62;62	G;G,C;T	62;61,1;62	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	63;63;63	T;A;C	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	4;4;4	G;A;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	4;4;4	T;C;G	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	306	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	350	30.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	584	586	GAA	288;286;286	G;A;A	288;286;286	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	872	874	GAT	282;283;283	G;A;T	282;283;283	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	995	997	TCA	280;279;279	T,C;C;A	279,1;279;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	D212N	NONSYN	634	636	GAT	1106	1108	AAT	242;242;244	A,T;A,T;T	241,1;241,1;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1124	1126	GTC	228;228;226	G;T;C	228;228;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1136	1138	TCT	222;225;227	T,G;C;T,C	221,1;225;226,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1355	1357	GGT	226;224;220	G;G,T,C;T,G	226;222,1,1;218,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1454	1456	GCA	248;247;248	G;C,A;A,C	248;246,1;247,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	1	SNP	p	G120K	1	.	.	358	360	AAG	830	832	AAG	264;265;269	A;A;G,T	264;265;268,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	1	SNP	p	A121D	1	.	.	361	363	GAC	833	835	GAC	270;275;275	G;A,C;C	270;274,1;275	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2934	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1890	193.0	1	SNP	p	D121N	0	.	.	361	363	GAC	833	835	GAC	270;275;275	G;A,C;C	270;274,1;275	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10006	rpoB	4179	4179	99.95	rpoB.l6.c4.ctg.1	5286	236.1	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2207	2209	AAT	258;255;258	A,C;A,T,C;T,G	257,1;252,2,1;256,2	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10006	rpoB	4179	4179	99.95	rpoB.l6.c4.ctg.1	5286	236.1	0	.	p	.	0	A1019V	NONSYN	3055	3057	GCC	3605	3607	GTC	269;268;267	G,A;T,G;C	268,1;267,1;267	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1396	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1406	123.6	1	SNP	p	V57M	1	.	.	169	171	ATG	708	710	ATG	233;232;228	A;T;G	233;232;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
